New FREE Continuing Education from MMWR and Medscape: Updated Recommendations for Use of Hepatitis A Vaccine for International Travel

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]



Title: New FREE Continuing Education from MMWR and Medscape: Updated Recommendations for Use of Hepatitis A Vaccine for International Travel

 

MMWR Logo



New FREE Continuing Education from MMWR and Medscape

Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel

CDC’s MMWR and Medscape are proud to introduce a new FREE continuing education (CE) activity. The activity describes current Advisory Committee on Immunization Practices recommendations for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel. It is based on a review of scientific evidence and consensus opinion.

The Advisory Committee on Immunization Practices has updated recommendations on the use of HepA vaccine for postexposure prophylaxis and the use of HepA vaccine in infants prior to international travel. Learn more and earn free CE with this training from CDC’s MMWR and Medscape. This activity is intended for infectious disease clinicians, family medicine practitioners, gastroenterologists, internists, pediatricians, nurses, pharmacists, public health officials, and other clinicians caring for patients for whom hepatitis A vaccine is recommended.

Upon completion of this activity, participants will be able to

  1. evaluate the current Advisory Committee on Immunization Practices recommendations for use of hepatitis A vaccine for postexposure prophylaxis, based on a review of scientific evidence and consensus,
  2. determine the current Advisory Committee on Immunization Practices recommendations for use of hepatitis A vaccine for preexposure prophylaxis for international travel, based on a review of scientific evidence and consensus opinion, and
  3. assess the clinical and public health implications of current Advisory Committee on Immunization Practices recommendations for use of hepatitis A vaccine postexposure prophylaxis and for preexposure prophylaxis for international travel, based on a review of scientific evidence and consensus opinion.

To access this free MMWR/Medscape CE activity, visit https://www.medscape.org/viewarticle/907498_6. If you are not a registered user on Medscape, register for free or login without a password and get unlimited access to all CE activities and other Medscape features.


Share this message with your networks!

Follow CDC on Facebook Follow CDC on Twitter
Updated recommendations from #ACIP specify new guidance for the use of #HepA #vaccine for #PEP for people over 40 and infants for international travel. Read the report and earn FREE CE: https://www.medscape.org/viewarticle/907498_6


[Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
  Powered by Linux